Who owns the OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW) trademark?

The OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW) trademark is owned by Bristol-Myers Squibb Company.

What class is the OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW) trademark registered in?

The OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW) trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW)?

The USPTO serial number for OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW) is 97342302.

What is the registration number for OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW)?

OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW) is registered under USPTO registration number 7130293.

OPD

USPTO Trademark Record

REGISTERED

OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW)

SN 97342302·Reg 7130293·Filed Apr 01, 2022

Owner Bristol-Myers Squibb Company

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW) (Serial No. 97342302), Registration No. 7130293, is a registered US trademark filed on Apr 01, 2022 by Bristol-Myers Squibb Company. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: August 08, 2029

Mark Intelligence

OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW) (Reg. #7130293) is a registered US trademark that has been protecting its owner, Bristol-Myers Squibb Company, since 2022. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Apr 01, 2022

SERIAL

97342302

REG#

7130293

REGISTERED

Aug 08, 2023

Owner

Applicant

Bristol-Myers Squibb Company

Entity

Corporation

State

Address

Route 206 & Province Line Road, Princeton, NJ, 08543

Country

Attorney

NameMarilyn F. Kelly

Law firm

Marilyn F. Kelly BRISTOL-MYERS SQUIBB COMPANY

Docket

00161293-US

Address

P.O. BOX 4000, TRADEMARK DEPT., MAILSTOP D.4243, PRINCETON, NJ 08648-4000, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateApr 01, 2022

Serial Number97342302

Registration No.7130293

Registration DateAug 08, 2023

Status DateAug 08, 2023

Published for OppositionMay 23, 2023

Mark TypeDesign with words

Attorney Docket00161293-US

Status DescriptionLive and registered

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Mar 22, 2022

First use in commerce: Mar 22, 2022

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

23 events

REGISTERED-PRINCIPAL REGISTER

Aug 08, 2023

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Aug 08, 2023

NOTICE OF REGISTRATION CONFIRMATION EMAILED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Aug 02, 2023

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Aug 02, 2023

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Aug 02, 2023

TEAS CHANGE OF CORRESPONDENCE RECEIVED

PUBLISHED FOR OPPOSITION

May 23, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 23, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 03, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Apr 17, 2023

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Apr 17, 2023

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Apr 17, 2023

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Apr 17, 2023

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 17, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 14, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 13, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 13, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Oct 14, 2022

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Oct 14, 2022

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 14, 2022

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Sep 30, 2022

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Apr 07, 2022

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 06, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Apr 05, 2022

NEW APPLICATION ENTERED

OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW)

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Bristol-Myers Squibb Company

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Marilyn F. Kelly

Resources

Company